Trinity Biotech PLC (TRIB)
1.57
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 18:30
Trinity Biotech Accounts Payable (Quarterly): 3.885M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.885M |
September 30, 2023 | 10.63M |
June 30, 2023 | 12.57M |
March 31, 2023 | 12.91M |
December 31, 2022 | 6.205M |
September 30, 2022 | 14.45M |
June 30, 2022 | 11.78M |
March 31, 2022 | 15.64M |
December 31, 2021 | 6.763M |
September 30, 2021 | 18.32M |
June 30, 2021 | 21.30M |
March 31, 2021 | 30.88M |
December 31, 2020 | 7.103M |
September 30, 2020 | 22.28M |
June 30, 2020 | 22.33M |
March 31, 2020 | 21.64M |
December 31, 2019 | 7.833M |
September 30, 2019 | 20.14M |
June 30, 2019 | 18.47M |
March 31, 2019 | 19.64M |
December 31, 2018 | 8.116M |
September 30, 2018 | 20.68M |
June 30, 2018 | 20.49M |
March 31, 2018 | 21.76M |
December 31, 2017 | 8.045M |
Date | Value |
---|---|
September 30, 2017 | 22.92M |
June 30, 2017 | 22.57M |
March 31, 2017 | 20.89M |
December 31, 2016 | 9.017M |
September 30, 2016 | 19.98M |
June 30, 2016 | 19.38M |
March 31, 2016 | 19.20M |
December 31, 2015 | 8.329M |
September 30, 2015 | 18.69M |
June 30, 2015 | 19.76M |
March 31, 2015 | 20.12M |
December 31, 2014 | 9.47M |
September 30, 2014 | 15.15M |
June 30, 2014 | 16.11M |
March 31, 2014 | 15.68M |
December 31, 2013 | 8.154M |
September 30, 2013 | 21.59M |
June 30, 2013 | 13.34M |
March 31, 2013 | 12.96M |
December 31, 2012 | 4.525M |
September 30, 2012 | 11.80M |
June 30, 2012 | 11.77M |
March 31, 2012 | 10.10M |
December 31, 2011 | 3.797M |
September 30, 2011 | 11.41M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.885M
Minimum
Dec 2023
30.88M
Maximum
Mar 2021
15.01M
Average
14.45M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
Amarin Corp PLC | 67.60M |
Avadel Pharmaceuticals PLC | 18.96M |
DBV Technologies SA | 18.08M |
Cellectis SA | 19.07M |
Adaptimmune Therapeutics PLC | 8.128M |